Skip to content

Small study shows women on stable HIV therapy have very low levels of HIV and high drug concentrations in genital fluids

Images from presentation by Anandi Sheth of Emory University School of Medicine, Division of Infectious Diseases, Atlanta, United States.

Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks

Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks

South Africa's PMTCT programme reduces mother-to-child transmission to under 4%

Thu-Ha Dinh of Centers for Disease Control and Prevention, USA, Global AIDS Program, Atalanta. ©IAS/Steve Forrest/Workers' Photos

Daily aciclovir slows HIV disease progression and reduces viral load

Image by Greta Hughson (aidsmap.com)

Viral suppression reduces HIV risk despite more sex and 'condom fatigue' in patients starting treatment in Cameroon

Viral suppression reduces HIV risk despite more sex and 'condom fatigue' in patients starting treatment in Cameroon

Testing project using social networks in rural Tanzania effective in identifying people with undiagnosed infection

Counsellors at the project in Tanzania. Image courtesy of Elizabeth Reddy.

How best to deploy point-of-care CD4 cell testing in resource-limited settings?

Dr Steven Reid of Imperial College, London. Image by Theo Smart (aidsmap.com)

Pre-exposure prophylaxis does work for women, two studies find

Michael C Thigpen and Jared Baeten ©IAS/Marcus Rose/Worker's Photos